JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB259162

Human STK38L (Ndr2) knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

STK38L KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon2 and 5 bp deletion in exon2 and Insertion of the selection cassette in exon2.

View Alternative Names

KIAA0965, NDR2, NDR2 protein kinase, Nuclear Dbf2-related kinase 2, ST38L_HUMAN, Serine/threonine-protein kinase 38-like, Stk38l, nuclear Dbf2 related 2

3 Images
Sanger Sequencing - Human STK38L (Ndr2) knockout HeLa cell lysate (AB259162)
  • Sanger seq

Unknown

Sanger Sequencing - Human STK38L (Ndr2) knockout HeLa cell lysate (AB259162)

Allele-2 : 1 bp insertion in exon2

Sanger Sequencing - Human STK38L (Ndr2) knockout HeLa cell lysate (AB259162)
  • Sanger seq

Unknown

Sanger Sequencing - Human STK38L (Ndr2) knockout HeLa cell lysate (AB259162)

Allele-1 : 5 bp deletion in exon2

Sanger Sequencing - Human STK38L (Ndr2) knockout HeLa cell lysate (AB259162)
  • Sanger seq

Unknown

Sanger Sequencing - Human STK38L (Ndr2) knockout HeLa cell lysate (AB259162)

Allele-3 : Insertion of the selection cassette in exon2

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon2 and 5 bp deletion in exon2 and Insertion of the selection cassette in exon2.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab259162-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human STK38L knockout HeLa cell lysate", "number":"AB259162-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB259162-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
STK38L
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

STK38L also known as Ndr2 is a member of the serine/threonine kinase family and shares similarities with other Ndr family members. This protein plays a significant mechanical role in several cellular processes including regulation of cell growth and cell division. STK38L has a molecular mass of approximately 54 kDa. Researchers have observed its expression in various human tissues such as liver kidney and heart indicating its widespread functional roles in the body.
Biological function summary

STK38L acts as an important regulator by coordinating cell cycle-related activities and influences apoptosis. It is known to participate as part of the larger signaling complex interacting with scaffold proteins to ensure proper cell function. The protein mediates these biological processes through phosphorylation impacting various signaling networks and helping cells respond to different physiological conditions effectively.

Pathways

STK38L integrates into key signaling pathways such as the Hippo pathway which is essential for controlling organ size through the regulation of cell proliferation and apoptosis. This pathway involves other proteins like MST1/2 and LATS1/2 which closely interact with STK38L to maintain cellular homeostasis. The interaction with these proteins illustrates STK38L's critical positioning in cellular communication networks affecting the pathway’s outcome on cellular behavior.

STK38L is associated with certain cancers and neurodegenerative disorders. Aberrant function or regulation of STK38L may contribute to the development of conditions such as hepatocellular carcinoma and Alzheimer's disease. BRCA1 and Tau proteins are related to these diseases where STK38L’s interaction with or regulation of these proteins can influence disease progression providing potential therapeutic targets for intervention.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com